Difficulty: Intermediate-Advanced | Prerequisites: Eukaryotic transcription regulation, post-transcriptional and post-translational regulation, cell cycle basics
This is where gene regulation meets the big questions: how does a single fertilised egg produce hundreds of distinct cell types? What happens when the regulatory machinery fails? Every cell in a multicellular organism shares the same genome, but differential gene expression determines which genes are active in each cell type. When the systems controlling growth and division break down, the result can be cancer. And beyond the DNA sequence itself, epigenetic tags can be inherited across generations. This material ties together everything from transcription regulation to real clinical outcomes.
Differential gene expression drives cell differentiation, with cytoplasmic determinants and inductive signals guiding early development and cell-specific enhancers controlling which genes are active in each tissue. Cancer arises when mutations convert proto-oncogenes into oncogenes or disable tumour-suppressor genes like p53, especially through a multistep accumulation of mutations. Epigenetic inheritance shows that chemical tags on DNA and histones can be passed to offspring without changing the DNA sequence.
Differential gene expression
The process by which cells with identical genomes express different subsets of genes, leading to different cell types. In simple terms, same recipe book, different pages open.
Cell differentiation
The process by which cells become specialised in structure and function. A stem cell differentiating into a neuron or a muscle cell is an example.
Stem cells
Undifferentiated cells with the potential to become various cell types. Bone marrow stem cells, for example, give rise to all the different blood cell types.
Cytoplasmic determinants
Maternal substances (mRNAs, proteins) distributed unevenly in the fertilised egg that influence early development. As the zygote divides, different daughter cells receive different determinants, leading to different patterns of gene expression.
Induction
The process by which signals from nearby cells influence gene expression and differentiation in a target cell. Think of it as neighbouring cells sending instructions about what to become.
Homeotic genes
Master regulator genes that direct the development of body segments or structures. They determine the identity of body parts along an organism's axis.
Hox genes
A specific set of homeotic genes arranged in clusters on chromosomes, found across animals from fruit flies to humans. Their position on the chromosome corresponds to the body region they control. Mutations in Hox genes can cause dramatic developmental defects, such as legs growing where antennae should be in a fruit fly.
Proto-oncogene
A normal cellular gene responsible for regulating cell growth and division. In simple terms, these are the genes that keep the cell cycle running properly under normal conditions.
Oncogene
A mutated or overexpressed version of a proto-oncogene that promotes uncontrolled cell growth. Think of it as a growth-promoting gene stuck in the "on" position.
Tumour-suppressor gene
A gene whose protein product inhibits the cell cycle, repairs damaged DNA, or promotes apoptosis (programmed cell death). When these genes are mutated and lose function, cells can divide uncontrollably.
p53
A tumour-suppressor gene that acts as a damage sensor. When DNA is damaged, p53 activates repair mechanisms or triggers cell death to prevent the damaged cell from dividing. It is mutated in approximately 50% of all human cancers.
Ras
A proto-oncogene involved in growth factor signalling. When mutated, the Ras protein is active even without a growth factor signal, leading to excessive cell division. Present in approximately 30% of human cancers.
BRCA1 / BRCA2
Tumour-suppressor genes associated with DNA repair. Inherited mutations in either gene significantly increase the risk of breast and ovarian cancer.
Epigenetic inheritance
The transmission of information from parent to offspring through chemical modifications to DNA or histones (such as methylation), rather than through changes to the DNA sequence itself.
Genomic imprinting
An epigenetic process in which certain genes are expressed in a parent-of-origin-specific manner. Methylation silences either the maternal or paternal allele of specific genes at the start of development.
Every cell in a multicellular organism contains the same genome, but different genes are expressed in different cell types.
Cell differentiation is the process by which cells become specialised in structure and function.
Cells are organised successively into tissues, organs, organ systems, and the whole organism.
Gene expression orchestrates the developmental programmes of animals. The key variable is not which genes are present, but which ones are turned on.
Expression levels are not simply on or off. They can vary continuously, giving cells a spectrum of activity for any given gene.
Stem cells are undifferentiated cells with the potential to become various cell types.
Bone marrow stem cells contribute different cell types to the blood (red blood cells, white blood cells, platelets).
Stem cell differentiation is driven by the same gene-regulatory mechanisms covered earlier: transcription factors, enhancers, and signalling pathways.
Cytoplasmic determinants are maternal substances (mRNAs, proteins) distributed unevenly in the fertilised egg.
As the zygote divides by mitosis, daughter cells receive different cytoplasmic determinants, which lead to different patterns of gene expression and differentiation.
The major source of developmental information is the environment around the cell, especially signals from nearby cells.
This process is called induction.
Signal transduction pathways relay these external signals to the nucleus, where they alter gene expression.
Inductive signals become more complex as the organism develops.
Different cell types have different sets of activator proteins available in their nuclei.
Enhancers are specific for different genes, giving different levels of gene expression in different tissues.
Example: a liver cell and a lens cell contain the same DNA, but the liver cell expresses the albumin gene (using the albumin enhancer and liver-specific activators), while the lens cell expresses the crystallin gene (using the crystallin enhancer and lens-specific activators).
Determinants are functionally useless without the correct enhancers and activators to act on them.
Homeotic genes are master regulators that direct the development of body segments or structures.
They are found across many animal species, including fruit flies, mice, and humans.
Hox genes are a specific family of homeotic genes arranged in clusters on chromosomes.
Their order on the chromosome corresponds to the body region they control (collinearity).
They are turned on by a cascade of regulatory genes: proteins encoded by early genes regulate the expression of later genes, creating a timed developmental sequence.
Genes in different clusters establish the identity of body segments along the head-to-tail (anterior-posterior) axis.
Mutations in Hox genes can cause dramatic and visible defects:
In Drosophila, legs growing where antennae should be (Antennapedia mutation).
These mutations demonstrate how tightly Hox gene regulation must be controlled.
Cancer results from genetic changes that affect cell cycle control.
The gene regulation systems that go wrong in cancer are the same systems involved in normal embryonic development.
Cancer can be caused by mutations in genes that normally regulate cell growth and division.
These mutations can arise from spontaneous errors, environmental influences (chemicals, radiation), or viruses.
Proto-oncogenes are normal cellular genes responsible for promoting cell growth and division.
When mutated, they become oncogenes, which drive uncontrolled cell growth.
Proto-oncogenes can become oncogenes through several mechanisms:
Translocation or transposition (gene moves to a new location under a different promoter).
Gene amplification (multiple copies of the gene are produced).
Point mutations in a control element or within the gene itself.
The result in each case is overproduction, hyperactivation, or abnormal expression of the growth-promoting protein.
Tumour-suppressor proteins normally repair damaged DNA, control cell adhesion, and act in signalling pathways that inhibit the cell cycle.
When tumour-suppressor genes are mutated and lose function, cells lose these braking mechanisms.
p53 is a tumour-suppressor gene that senses DNA damage.
When damage is detected, p53 activates repair mechanisms, coordinates miRNAs for DNA repair, or triggers apoptosis ("suicide genes") to prevent the damaged cell from dividing.
Mutated in approximately 50% of all human cancers, leading to increased cell division because the damage checkpoint is lost.
Ras is a proto-oncogene involved in growth factor signalling.
In the normal pathway: growth factor binds receptor, receptor activates Ras (via GTP), Ras activates protein kinases, kinases activate transcription factors, cell divides.
When Ras is mutated, the Ras protein remains active with or without a growth factor signal, leading to uncontrolled cell division.
Present in approximately 30% of human cancers.
A cancerous cell is usually characterised by at least one active oncogene and the loss of tumour-suppressor gene function.
Multiple mutations are generally needed for a cell to become fully cancerous. This is why cancer incidence increases with age.
A cell typically becomes malignant when both growth-promoting pathways (like Ras) and growth-inhibiting pathways (like p53) fail simultaneously.
Example (colon cancer progression): loss of APC tumour suppressor, then activation of Ras oncogene, then loss of SMAD4 tumour suppressor, then loss of p53, then additional mutations. Each step moves from normal tissue through benign growths (polyps, adenomas) to malignant carcinoma.
Oncogenes, mutant alleles, or tumour-suppressor genes can be inherited.
Mutations in BRCA1 or BRCA2 (breast cancer genes) significantly increase the risk of breast and ovarian cancer.
Viruses can also contribute to cancer development. It does not have to be purely inherited.
Inheritance can occur through mechanisms beyond the DNA sequence itself.
Epigenetic tags (such as methyl groups on DNA or chemical modifications on histone tails) can be passed from parent to offspring.
DNA methylation regulates expression of maternal or paternal alleles of certain genes at the start of development (genomic imprinting).
Epigenetic changes to chromatin can result from development (in utero, childhood), environmental chemicals, drugs, ageing, and diet.
These changes may lead to cancer, autoimmune disease, mental disorders, or diabetes.
Example: smoking and drug use during pregnancy can alter epigenetic tags in the developing baby, with effects that may persist across generations.
Students often think cancer is caused by a single mutation. In most cases, multiple mutations must accumulate (the multistep model) before a cell becomes fully cancerous.
A common error is confusing proto-oncogenes with oncogenes. Proto-oncogenes are normal, necessary genes. Oncogenes are their mutated, overactive forms.
Students sometimes think all cells in the body express different genes because they have different DNA. They do not. All cells (with rare exceptions) carry the same genome. The difference is in which genes are expressed.
Epigenetic inheritance is frequently misunderstood as a change to the DNA sequence. It is not. Epigenetic changes alter gene expression through chemical tags (methylation, histone modification) without changing the underlying sequence.
⚠️ Be able to explain why all cells have the same DNA but different structures and functions (differential gene expression, cell-specific enhancers and activators).
⚠️ Know the difference between cytoplasmic determinants (intrinsic, maternal) and induction (extrinsic, from neighbouring cells).
⚠️ Understand the p53 and Ras pathways and what happens when each is mutated. This is heavily tested.
⚠️ Be prepared to trace the multistep model of cancer development (e.g., colon cancer progression from normal cells to malignant tumour).
⚠️ Know what Hox genes are and what happens when they mutate (displaced body structures).
⚠️ Understand that epigenetic tags can be inherited across generations without changes to the DNA sequence itself.
True or False: Different cell types in the same organism have different DNA sequences.
Fill in the blank: Maternal substances in the fertilised egg that influence early development are called ______.
True or False: A single mutation is usually sufficient to cause cancer.
Fill in the blank: The tumour-suppressor gene ______ is mutated in approximately 50% of all human cancers.
True or False: Epigenetic inheritance involves changes to the DNA sequence.
Answers: 1. False (same genome, different expression), 2. Cytoplasmic determinants, 3. False (multiple mutations are usually required), 4. p53, 5. False (it involves chemical tags, not sequence changes)
Q: How do cytoplasmic determinants and induction differ as sources of developmental information?
A: Cytoplasmic determinants are maternal substances already present in the egg, distributed unevenly so that daughter cells inherit different determinants during division. Induction is an external process in which signals from neighbouring cells influence gene expression in a target cell. One is intrinsic (built into the egg), the other is extrinsic (received from the environment).
Q: Explain how a proto-oncogene becomes an oncogene. Give at least two mechanisms.
A: A proto-oncogene can become an oncogene through translocation (the gene moves to a new chromosomal location under a more active promoter), gene amplification (multiple copies are produced, leading to excess protein), or point mutation (within the gene or its control element, producing a hyperactive or degradation-resistant protein).
Q: Describe the normal function of p53 and explain what happens when it is mutated.
A: Normally, p53 senses DNA damage and responds by activating repair mechanisms, coordinating miRNAs for repair, or triggering apoptosis to prevent the damaged cell from dividing. When p53 is mutated, the cell loses this checkpoint. Damaged DNA is replicated and passed on, and the cell divides unchecked, contributing to cancer development.
Q: Why does cancer incidence increase with age?
A: Cancer typically requires multiple mutations to accumulate in the same cell lineage (the multistep model). The longer an organism lives, the more opportunities there are for mutations to occur through spontaneous errors, environmental exposure, or viral infection. Over time, it becomes more likely that enough mutations will accumulate to disable both growth-promoting and growth-inhibiting pathways.
Q: What is epigenetic inheritance, and how does it differ from genetic inheritance?
A: Genetic inheritance involves passing on DNA sequences from parent to offspring. Epigenetic inheritance involves passing on chemical modifications to DNA or histones (such as methylation patterns) that alter gene expression without changing the underlying DNA sequence. Environmental factors such as diet, chemicals, and drugs can influence these epigenetic tags, and the effects can persist across generations.
This material builds on the transcription regulation and post-transcriptional control covered in the previous study notes. The enhancer and transcription factor mechanisms from those topics are what drive cell-specific gene expression here. The cancer section connects directly to cell cycle regulation (cyclins, CDKs, checkpoints). Epigenetic inheritance links to DNA methylation and chromatin modification, covered earlier as mechanisms of gene silencing. Understanding these connections is essential for seeing how the course fits together.
Differential gene expression, cell differentiation, stem cells, cytoplasmic determinants, induction, inductive signals, signal transduction, homeotic genes, Hox genes, Antennapedia, collinearity, proto-oncogene, oncogene, tumour-suppressor gene, tumor suppressor, p53, Ras, BRCA1, BRCA2, multistep model of cancer, gene amplification, translocation, point mutation, ubiquitin, proteasome, kinase, apoptosis, epigenetic inheritance, DNA methylation, histone modification, genomic imprinting, epigenetics, chromatin remodelling, BIO 311C